Understand the source comparison
How Is Enclomiphene Different From Clomiphene? (Enclomiphene vs Clomiphene)
The most common point of confusion in this area is the relationship between enclomiphene vs clomiphene. They are not two separate drugs discovered independently; enclomiphene is literally one of the two ingredients inside clomiphene. When a clinician prescribe
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The most common point of confusion in this area is the relationship between enclomiphene vs clomiphene. They are not two separate drugs discovered independently; enclomiphene is literally one of the two ingredients inside clomiphene. When a clinician prescribes clomiphene off-label to a man with low testosterone, that man receives both isomers. When a researcher studies enclomiphene, they study only the trans-isomer, purified. This is analogous to the difference between a racemic drug and a single-enantiomer version, except that here the isomers are geometric (cis/trans around a double bond) rather than optical.
- The functional consequences of this purification have been probed most directly in animal work. A chronic oral-dosing toxicology study in male mice compared isolated enclomiphene citrate against isolated zuclomiphene citrate at matched doses. The two isomers produced strikingly different profiles: zuclomiphene treatment was associated with adverse effects on Leydig cells, epididymis, seminal vesicles, and kidneys, along with changes in testosterone, FSH, and LH, whereas the isolated enclomiphene isomer had positive effects on testosterone production and no adverse effects on testicular histology.[5] The authors framed this as a rationale for developing a mono-isomeric enclomiphene preparation rather than continuing to rely on the mixture. It is important to read that study for exactly what it is: a preclinical, animal-only investigation of the two isomers’ reproductive-tissue effects, not a demonstration of human safety or efficacy.
- There is a second, regulatory layer to the difference. Clomiphene citrate is an FDA-approved drug — but only for the treatment of ovulatory dysfunction in women seeking to conceive. It has no FDA-approved indication in men; every use of clomiphene for male hypogonadism or male infertility is off-label.[8] Enclomiphene, by contrast, has no FDA approval for any indication at all — it never cleared the approval process despite completing late-stage trials. So the honest summary is: clomiphene is an approved women’s fertility drug used off-label in men, while enclomiphene is an unapproved investigational compound that was studied specifically for men but never authorized.
- Composition
- ~62% enclomiphene + ~38% zuclomiphene
- Trans-(E)-isomer only
- FDA status
- Approved for female anovulatory infertility; off-label in men
- Not FDA-approved for any indication
- Clearance profile
- Mixed; zuclomiphene component persists for weeks
- Relatively rapid clearance (hours to days)
- Development name
- Clomid, Serophene
- Androxal (Repros Therapeutics)
- Primary research population
- Women (approved); men (off-label)
- Men with secondary hypogonadism (investigational)